Issue 7, 2015

Novel difluoroacetamide analogues of agomelatine and melatonin: probing the melatonin receptors for MT1 selectivity

Abstract

Synthesis and pharmacological evaluation of novel agomelatine and melatonin analogues with structures combining the features generating MT1 selectivity, namely the bulky hydrophobic ether moiety and the difluoroacetamide group, is reported. The dimeric agomelatine analogue linked by a three methylene spacer displayed the best affinity (Ki = 1.2 nM) and selectivity (7-fold) toward MT1 receptors.

Graphical abstract: Novel difluoroacetamide analogues of agomelatine and melatonin: probing the melatonin receptors for MT1 selectivity

Supplementary files

Article information

Article type
Concise Article
Submitted
30 Apr 2015
Accepted
08 Jun 2015
First published
08 Jun 2015

Med. Chem. Commun., 2015,6, 1340-1344

Novel difluoroacetamide analogues of agomelatine and melatonin: probing the melatonin receptors for MT1 selectivity

D. P. Zlotos, N. M. Riad, M. B. Osman, B. R. Dodda and P. A. Witt-Enderby, Med. Chem. Commun., 2015, 6, 1340 DOI: 10.1039/C5MD00190K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements